Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05879133 · ClinicalTrials.gov registry record · NA

HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia

A NA study of Chronic Lymphocytic Leukemia, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05879133 is a NA study of Chronic Lymphocytic Leukemia that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants, below the 182-participant average among 187 other Chronic Lymphocytic Leukemia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05879133, a NA study of Chronic Lymphocytic Leukemia, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

To learn if exercise and weight management can help to improve feelings of fatigue in CLL survivors.

Interventions

  • BEHAVIORAL Questionnaires
  • OTHER Fit Bit

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-05-17
Est. Completion 2027-07-03
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05879133

The ClinicalTrials.gov registry entry for NCT05879133 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 182-participant average among 187 other Chronic Lymphocytic Leukemia trials with a reported enrollment target (84% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Lymphocytic Leukemia appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.

NCT05879133 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05879133 about?

NCT05879133 is a clinical study titled "HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia". To learn if exercise and weight management can help to improve feelings of fatigue in CLL survivors.

What is the current status of trial NCT05879133?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-05-17. Estimated completion is 2027-07-03.

What conditions does trial NCT05879133 study?

This clinical trial studies the following conditions: Chronic Lymphocytic Leukemia.

What interventions are being tested in trial NCT05879133?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Fit Bit (OTHER).

Who is sponsoring clinical trial NCT05879133?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05879133 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Lymphocytic Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.